A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

September 13, 2023

Primary Completion Date

May 17, 2027

Study Completion Date

July 12, 2027

Conditions
Systemic Sclerosis Associated Interstitial Lung DiseaseScleroderma, Systemic
Interventions
BIOLOGICAL

Belimumab

Belimumab will be administered.

OTHER

Placebo

.Placebo will be administered.

Trial Locations (130)

2170

COMPLETED

GSK Investigational Site, Liverpool

3065

RECRUITING

GSK Investigational Site, Fitzroy

4000

RECRUITING

GSK Investigational Site, Liège

5000

RECRUITING

GSK Investigational Site, Adelaide

WITHDRAWN

GSK Investigational Site, Odense C

5011

RECRUITING

GSK Investigational Site, Woodville

8200

RECRUITING

GSK Investigational Site, Aarhus

9000

RECRUITING

GSK Investigational Site, Ghent

10021

RECRUITING

GSK Investigational Site, New York

10043

RECRUITING

GSK Investigational Site, Orbassano to

11201

RECRUITING

GSK Investigational Site, New York

11527

WITHDRAWN

GSK Investigational Site, Athens

12462

RECRUITING

GSK Investigational Site, Athens

13676

RECRUITING

GSK Investigational Site, Potsdam

15208

RECRUITING

GSK Investigational Site, Poria – Neve Oved

16499

RECRUITING

GSK Investigational Site, Suwon Kyunggi-do

18016

RECRUITING

GSK Investigational Site, Granada

19104

RECRUITING

GSK Investigational Site, Philadelphia

19140

RECRUITING

GSK Investigational Site, Philadelphia

20007

RECRUITING

GSK Investigational Site, Washington D.C.

20122

RECRUITING

GSK Investigational Site, Milan

20520

RECRUITING

GSK Investigational Site, Turku

21224

RECRUITING

GSK Investigational Site, Baltimore

27000

RECRUITING

GSK Investigational Site, Torreón

27100

RECRUITING

GSK Investigational Site, Pavia

28007

RECRUITING

GSK Investigational Site, Madrid

28046

RECRUITING

GSK Investigational Site, Madrid

29609

RECRUITING

GSK Investigational Site, Brest

31000

RECRUITING

GSK Investigational Site, Chihuahua City

31059

RECRUITING

GSK Investigational Site, Toulouse

32429

RECRUITING

GSK Investigational Site, Minden

32610

RECRUITING

GSK Investigational Site, Jacksonville

33144

RECRUITING

GSK Investigational Site, Miami

35128

RECRUITING

GSK Investigational Site, Padua

36200

RECRUITING

GSK Investigational Site, VigoPontevedra

37134

RECRUITING

GSK Investigational Site, Verona

40225

RECRUITING

GSK Investigational Site, Düsseldorf

41013

RECRUITING

GSK Investigational Site, Seville

41110

RECRUITING

GSK Investigational Site, Larissa

41125

RECRUITING

GSK Investigational Site, Modena

44124

RECRUITING

GSK Investigational Site, Ferrara

44281

RECRUITING

GSK Investigational Site, Kfar Saba

44650

RECRUITING

GSK Investigational Site, Guadalajara

45206

RECRUITING

GSK Investigational Site, Cincinnati

46026

RECRUITING

GSK Investigational Site, Valencia

48013

RECRUITING

GSK Investigational Site, Bilbao

48109

RECRUITING

GSK Investigational Site, Ann Arbor

50134

RECRUITING

GSK Investigational Site, Florence

51149

RECRUITING

GSK Investigational Site, Cologne

52621

RECRUITING

GSK Investigational Site, Ramat Gan

55131

RECRUITING

GSK Investigational Site, Mainz

58100

WITHDRAWN

GSK Investigational Site, Holon

60126

RECRUITING

GSK Investigational Site, Ancona

60611

RECRUITING

GSK Investigational Site, Chicago

70124

RECRUITING

GSK Investigational Site, Bari

71110

RECRUITING

GSK Investigational Site, Heraklion Crete

72076

RECRUITING

GSK Investigational Site, Tübingen

75014

RECRUITING

GSK Investigational Site, Paris

RECRUITING

GSK Investigational Site, Paris

75020

RECRUITING

GSK Investigational Site, Denison

75651

RECRUITING

GSK Investigational Site, Paris

77030

RECRUITING

GSK Investigational Site, Houston

79902

RECRUITING

GSK Investigational Site, El Paso

80033

RECRUITING

GSK Investigational Site, Aurora

80131

RECRUITING

GSK Investigational Site, Napoli

85027

RECRUITING

GSK Investigational Site, Phoenix

85258

RECRUITING

GSK Investigational Site, Scottsdale

85259

RECRUITING

GSK Investigational Site, Scottsdale

85724

RECRUITING

GSK Investigational Site, Tucson

90095

RECRUITING

GSK Investigational Site, Los Angeles

RECRUITING

GSK Investigational Site, Los Angeles

90301

RECRUITING

GSK Investigational Site, Los Angeles

91786

RECRUITING

GSK Investigational Site, Upland

93000

RECRUITING

GSK Investigational Site, Bobigny

95123

RECRUITING

GSK Investigational Site, Catania

100020

RECRUITING

GSK Investigational Site, Beijing

100191

RECRUITING

GSK Investigational Site, Beijing

100730

RECRUITING

GSK Investigational Site, Beijing

RECRUITING

GSK Investigational Site, Beijing

110001

RECRUITING

GSK Investigational Site, Shenyang

130021

RECRUITING

GSK Investigational Site, Changchun

200001

RECRUITING

GSK Investigational Site, Shanghai

200040

RECRUITING

GSK Investigational Site, Shanghai

210008

RECRUITING

GSK Investigational Site, Nanjing

210029

RECRUITING

GSK Investigational Site, Nanjing

412007

RECRUITING

GSK Investigational Site, Zhuzhou

530000

RECRUITING

GSK Investigational Site, Nanning

610041

RECRUITING

GSK Investigational Site, Chengdu

610072

RECRUITING

GSK Investigational Site, Chengdu

648000

RECRUITING

GSK Investigational Site, Luzhou

710061

RECRUITING

GSK Investigational Site, Xi'an

3436212

RECRUITING

GSK Investigational Site, Haifa

6423906

RECRUITING

GSK Investigational Site, Tel Aviv

30150221

RECRUITING

GSK Investigational Site, Belo Horizonte

08901

RECRUITING

GSK Investigational Site, New Brunswick

Unknown

RECRUITING

GSK Investigational Site, Buenos Aires

RECRUITING

GSK Investigational Site, Ciudad Autonoma de Buenos Aire

RECRUITING

GSK Investigational Site, Porto Alegre

RECRUITING

GSK Investigational Site, Mianyang

C1015ABO

RECRUITING

GSK Investigational Site, Ciudad Autonoma Buenos Aires

80440-080

RECRUITING

GSK Investigational Site, Curitiba

36010-570

RECRUITING

GSK Investigational Site, Juiz de Fora

90020-090

RECRUITING

GSK Investigational Site, Porto Alegre

40.150-150

RECRUITING

GSK Investigational Site, Salvador

01308-050

RECRUITING

GSK Investigational Site, São Paulo

04038-002

RECRUITING

GSK Investigational Site, São Paulo

546 36

RECRUITING

GSK Investigational Site, Thessaloniki

09042

RECRUITING

GSK Investigational Site, Cagliari

00161

RECRUITING

GSK Investigational Site, Roma

00186

RECRUITING

GSK Investigational Site, Roma

371-8511

RECRUITING

GSK Investigational Site, Gunma

734-8551

RECRUITING

GSK Investigational Site, Hiroshima

060-8543

RECRUITING

GSK Investigational Site, Hokkaido

060-8648

RECRUITING

GSK Investigational Site, Hokkaido

236-0051

WITHDRAWN

GSK Investigational Site, Kanagawa

980-8574

RECRUITING

GSK Investigational Site, Miyagi

431-3192

RECRUITING

GSK Investigational Site, Shizuoka

770-8503

RECRUITING

GSK Investigational Site, Tokushima

113-8603

RECRUITING

GSK Investigational Site, Tokyo

CP 97070

RECRUITING

GSK Investigational Site, Mérida

04763

RECRUITING

GSK Investigational Site, Seoul

05505

RECRUITING

GSK Investigational Site, Seoul

06591

RECRUITING

GSK Investigational Site, Seoul

140 887

RECRUITING

GSK Investigational Site, Seoul

08025

RECRUITING

GSK Investigational Site, Barcelona

08035

RECRUITING

GSK Investigational Site, Barcelona

B15 2GW

RECRUITING

GSK Investigational Site, Birmingham

LS7 4SA

RECRUITING

GSK Investigational Site, Leeds

NW3 2QG

RECRUITING

GSK Investigational Site, London

WF1 4DG

RECRUITING

GSK Investigational Site, Wakefield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT05878717 - A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease | Biotech Hunter | Biotech Hunter